August 30, 2008

Become a Member! | Newsletter Sign Up | Login
subglobal1 link | subglobal1 link | subglobal1 link | subglobal1 link | subglobal1 link | subglobal1 link | subglobal1 link
subglobal2 link | subglobal2 link | subglobal2 link | subglobal2 link | subglobal2 link | subglobal2 link | subglobal2 link
subglobal3 link | subglobal3 link | subglobal3 link | subglobal3 link | subglobal3 link | subglobal3 link | subglobal3 link
subglobal4 link | subglobal4 link | subglobal4 link | subglobal4 link | subglobal4 link | subglobal4 link | subglobal4 link
subglobal5 link | subglobal5 link | subglobal5 link | subglobal5 link | subglobal5 link | subglobal5 link | subglobal5 link
subglobal6 link | subglobal6 link | subglobal6 link | subglobal6 link | subglobal6 link | subglobal6 link | subglobal6 link
subglobal7 link | subglobal7 link | subglobal7 link | subglobal7 link | subglobal7 link | subglobal7 link | subglobal7 link
subglobal8 link | subglobal8 link | subglobal8 link | subglobal8 link | subglobal8 link | subglobal8 link | subglobal8 link

Education.NATF

Our objective is to improve patient care through the advancement of thrombosis education. Our approach is multidisciplinary, targeting office-based physicians, hospitalists, nurse practitioners, nurses, pharmacists, physician assistants, and hospital administrators.

In addition to health care professionals, NATF co-sponsors "Proactive Thrombosis Prevention," an annual event geared to health care professionals, patients, and caregivers. This unique educational experience allows patients and their families one-on-one interaction with the professionals who treat them.

Mark your calendars for "Thrombosis Summit 2008," to be held in Boston on Saturday, September 27, 2008. This 1-day symposium emphasizing Clinical Science and professional education is intended to provide a concise state-of-the-art overview of prophylaxis measures and critical developments in the diagnosis treatment, and prevention of thrombotic disorders.

Our legacy will be to support innovative educational programs related to thrombosis issues. We will strive to maintain a comprehensive list of thrombosis educational events. Event submissions from all thrombosis organizations are welcome.

If you have an upcoming thrombosis educational event you would like to advertise on our web site, please email your program information to: info@NATFonline.org

Upcoming Live Thrombosis Education Events

Online CME Programs in Venous and Cardiovascular Thrombosis

  • Thrombosis Summit 2008Saturday, September 27, 2008REGISTER TODAY for the North American Thrombosis Forum "Thrombosis Summit 2008," to be held in Boston on Saturday, September 27, 2008. This 1-day symposium emphasizing Clinical Science and professional education is intended to provide a concise state-of-the-art overview of prophylaxis measures and critical developments in the diagnosis treatment, and prevention of thrombotic disorders.
  • Bleeding and Thrombosing Diseases: 2008 Mayo Update Coagulation Conference, Rochester, MNAugust 12 – 15, 2008Wet Workshop (August 12) - Following orientation presentations, participants will form teams for testing and evaluation of four "unknown" plasma specimens using coagulation instrumentation, reagents and technical specialists at each of six workstations. Following testing and evaluation, workshop faculty will lead a discussion of results and interpretations, including comments about the clinical disorders studied and the comparability or diversity of results and interpretations obtained with different instruments or reagents. Participation is limited to 150 registrants. Coagulation Conference (August 13-15) This 13th Mayo coagulation conference will provide reviews and updates about laboratory and clinical aspects of bleeding and thrombosing disorders. Didactic presentations will be supplemented with panel discussions and case presentations. Adequate time will be allocated for questions. New features for 2008 include: 1) Four 'Breakfast-with-the-Experts' interactive educational sessions (repeated Thursday and Friday mornings); 2) Conference length extended from 2 to 2.5 days, adjourning Friday noon.
  • Venous Thromboembolism: from Bench to BedsideSeptember 11-13, 2008SAVE THE DATE for the Venous Thromboembolism: From Bench to Bedside symposium to be held at the George Watts Hill Alumni Center, The University of North Carolina at Chapel Hill.  This program is presented by the Division of Hematology/Oncology, Department of Medicine, and sponsored by the School of Medicine of The University of North Carolina at Chapel Hill.  Please visit the program website for brochure and registration form in June, 2008.
  • Antithrombosis Therapy Management: Module 1 Traditional Oral Anticoagulants [Online]This module will cover the pharmacology, therapeutics, and drug interactions of oral anticoagulant therapy. After reviewing this module the participant will be familiar with proper indications for oral anticoagulation, goal of treatment, length of treatment, patient monitoring issues, and potential interactions with warfarin therapy. Objectives: Discuss proper indications, duration and intensity for oral anticoagulation therapy; List proper monitoring parameters for patients receiving warfarin therapy; Identify key educational elements for patients on warfarin therapy; Recommend proper warfarin dosing and frequency of patient follow up; List side effects associated with oral anticoagulants; Identify drug-drug, drug-diet, drug-disease state interactions with warfarin. The University of Illinois at Chicago College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Completion of the evaluation form and a passing grade of 70% or better on the self-assessment questions are pre-requisites for receiving continuing education credit. A statement of credit verifying 0.5 CEUs (5 contact hours) will be available to the participant the completion of the pre-requisites.
  • Case-Oriented Symposium on Bleeding and ThrombosisSaturday, September 24-25, 2008The Symposium on Bleeding and Thrombosis, hosted by Nichols Institute for Coagulation, is an entirely case-oriented seminar designed for healthcare professionals involved in the diagnosis and management of hemostasis and thrombotic disorders. Presented by leading experts, topics will include Lupus Anticoagulant/Antiphospholipid Antibody Syndrome, D-Dimer, Thrombotic Thrombocytopenia Purpura, von Willebrand's Disease, Thrombophilia, Thrombin-Generation Potential, Platelet Disorders and more.
  • Venous Thrombosis – Program Faculty: Kenneth A. Bauer, MD, David Feinbloom, MD [Webcast]The most common presentations of venous thromboembolism (VTE) are deep vein thrombosis (DVT) of the lower extremity and pulmonary embolism. A risk factor for VTE, either hereditary or acquired, can now be identified in approximately 80 percent of patients. Furthermore, there is often more than one factor at play in a given patient. As an example, 50 percent of thrombotic events in patients with inherited thrombophilia are associated with an acquired risk factor (eg, surgery, pregnancy, oral contraceptives). In addition, some patients have more than one form of inherited thrombophilia and appear to be at greater risk for thrombosis. The approach to the adult patient with deep venous thrombosis will be discussed here with an emphasis upon the use of diagnostic tests to establish an accurate diagnosis and the initiation of anticoagulant therapy. Indications for testing for an inherited cause of thrombophilia are addressed along with the potential implications of the discovery of an underlying thrombophilic defect for the patient and affected relatives. Harvard Medical School designates this educational activity for a maximum of 1 category 1 credits toward the AMA Physician's Recognition Award™.
  • Mayo Clinic Presents: Human Factors in Healthcare: Practical Applications for Improving Patient Safety, in Rochester, MNOctober 1-3, 2008This conference will build on the previous year's conference. It will serve as an introduction for all people in healthcare who want to learn how human factors can improve patient safety. Because patient safety is a top priority for healthcare organizations, the interaction between people and their technological environment contributes to the safety of systems and processes within healthcare. This conference will provide a forum dedicated to understanding the core elements of human factors science and how these elements contribute to system safety to ultimately improve quality of patient care.
  • 4th Annual Thrombosis and Hematology Update, Hamilton, ON, CANADAOctober 3-5, 2008McMaster University presents the 4th Annual Thrombosis and Hematology Update Objectives: To obtain a clinically relevant overview of the management of common thromboembolic disorders; to discuss consequences of the treatment of hematologic diseases; to discuss optimal use of antithrombotic therapy. Target Audience: Allied health care professionals, Family Physicians, Internists, and Subspecialists who deal with patients who have thromboembolic disease or who have been treated for hematologic disorders.
  • XXXII World Congress of the International Society of Hematology (ISH 2008), Bangkok, ThailandOctober 19-23, 2008The Congress is designed to present the most up-to-date scientific discoveries and practices in varied fields of Hematology. The scientific forums will include education program, symposia, plenary sessions and concurrent sessions.  It will give all the participants a chance to share the latest experience and knowledge, and will provide us with the unique opportunity to make a further collaboration among physicians and scientists working in these fields.
  • Canadian Cardiovascular Congress, Toronto, Ontario CANADAOctober 25-29, 2008The Canadian Cardiovascular Society (CCS) is the national voice for cardiovascular physicians and scientists in Canada.  The CCS mission is to promote cardiovascular health and care through: 1) knowledge translation, including dissemination of research, and 2) encouragement of best practices, professional development, and leadership in health policy.  Save the date for the annual CCS Congress in Toronto, Ontario, October 25-29, 2008 to be held at the Metro Toronto Convention Centre.
  • The American Society of Hematology 50th Annual Meeting and Exposition, San Francisco, CADecember 6-9, 2008The Congress is designed to present the most up-to-date scientific discoveries and practices in varied fields of Hematology. The scientific forums will include education program, symposia, plenary sessions and concurrent sessions.  It will give all the participants a chance to share the latest experience and knowledge, and will provide us with the unique opportunity to make a further collaboration among physicians and scientists working in these fields.
  • Promoting Minorities in Hematology Presentations and Reception: ASH 2008, San Francisco, CA December 6, 2008: 6:30 p.m. – 9:00 p.mASH invites all interested meeting attendees to this event highlighting training and research opportunities for minorities underrepresented in hematology. The reception will include poster presentations by students participating in the National Heart, Lung, and Blood Institute's Minority Research Supplement, a series of oral research presentations by the 2008 Minority Medical Student Award Program participants, and an announcement about theASH-AMFDP Award (a partnership between ASH and the Harold Amos Medical Faculty Development Program of the Robert Wood Johnson Foundation).  Representatives from the National Institutes of Health will also be in attendance to provide information about their training and research offerings. The event will conclude with a buffet dinner and networking
About Us |Terms of Use & Privacy Policy | Contact Us | Media Relations | ©2008 North American Thrombosis Forum, Inc.
Google search
WWW www.natfonline.org